SLT 0.00% 0.7¢ select exploration limited

genelabs technology evaluation completion soon

  1. 7,409 Posts.

    As per the 24th Spetember announcement 'Select Vaccine first international deal: Hepatitis E rapid diagnostic',

    'The completion of the technology evaluation process currently underway is anticipated by the end of
    October 2003. Following this, the detailed licensing contract is expected to be executed between Genelabs
    Diagnostics and Select Vaccines shortly thereafter'

    Based on this I would expect that an announcement would be forthcoming in the next week or two. Anyone have updated information on this?


arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.